Genenta Science S.p.A. cash flow statement GNTA
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GNTA (Nasdaq)
- Incorporated in
- Italy
- Headquarters
- Milan, Italy
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1838716
- Former names
- Genenta Science S.r.l. (until May 19, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.